THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Paul Boylan

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Disease, Chronic Obstructive
2
2024
62
1.430
 Why?
Pharmacists
2
2024
69
1.000
 Why?
Cannabinoids
1
2024
8
0.960
 Why?
Methocarbamol
1
2024
1
0.930
 Why?
Sleep Apnea, Obstructive
1
2024
38
0.920
 Why?
Polyethylene Glycols
1
2024
93
0.870
 Why?
Asthma
1
2024
57
0.850
 Why?
Students, Pharmacy
1
2024
74
0.830
 Why?
Rhabdomyolysis
1
2022
6
0.800
 Why?
Muscular Diseases
1
2022
12
0.800
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2022
58
0.770
 Why?
Dermal Fillers
1
2021
1
0.750
 Why?
Ocular Hypertension
1
2020
11
0.730
 Why?
Patient Transfer
2
2018
42
0.730
 Why?
Glaucoma, Open-Angle
1
2020
22
0.720
 Why?
Pulmonary Embolism
1
2021
126
0.680
 Why?
Megestrol Acetate
1
2019
5
0.670
 Why?
Rivaroxaban
1
2019
28
0.660
 Why?
Gastrointestinal Hemorrhage
1
2019
46
0.640
 Why?
Pharmacy Residencies
1
2018
6
0.600
 Why?
Accreditation
1
2018
33
0.600
 Why?
Education, Pharmacy, Graduate
1
2018
17
0.590
 Why?
Self Care
1
2018
41
0.590
 Why?
Heart Failure
1
2018
232
0.490
 Why?
Humans
11
2024
26856
0.460
 Why?
Aftercare
2
2024
32
0.410
 Why?
Patient Discharge
2
2024
96
0.390
 Why?
Excipients
1
2024
4
0.230
 Why?
Acidosis
1
2024
11
0.230
 Why?
Administration, Intravenous
1
2024
25
0.230
 Why?
Social Workers
1
2024
5
0.230
 Why?
Bronchodilator Agents
1
2024
15
0.230
 Why?
Patients
1
2024
17
0.230
 Why?
Kidney Diseases
1
2024
58
0.220
 Why?
Adrenal Cortex Hormones
1
2024
74
0.220
 Why?
Interprofessional Relations
1
2024
63
0.220
 Why?
Mental Health
1
2024
96
0.210
 Why?
Drug Overdose
1
2022
10
0.210
 Why?
Colchicine
1
2022
15
0.200
 Why?
Drug Interactions
1
2022
77
0.190
 Why?
Medication Therapy Management
1
2021
18
0.180
 Why?
Ophthalmic Solutions
1
2020
27
0.180
 Why?
beta-Alanine
1
2020
12
0.180
 Why?
Benzoates
1
2020
30
0.180
 Why?
Cross-Sectional Studies
1
2024
915
0.180
 Why?
Intraocular Pressure
1
2020
61
0.180
 Why?
Antihypertensive Agents
1
2020
57
0.180
 Why?
Case-Control Studies
1
2022
701
0.170
 Why?
Polymers
1
2021
114
0.170
 Why?
Dabigatran
1
2019
20
0.170
 Why?
Florida
1
2019
54
0.170
 Why?
Retrospective Studies
2
2022
2444
0.160
 Why?
Treatment Outcome
1
2024
2267
0.150
 Why?
Accountable Care Organizations
1
2018
3
0.150
 Why?
Outpatients
1
2018
42
0.150
 Why?
Professional Role
1
2018
42
0.150
 Why?
Self-Management
1
2018
12
0.150
 Why?
Patient Care Team
1
2018
62
0.150
 Why?
Pharmaceutical Services
1
2018
40
0.140
 Why?
Patient Readmission
1
2018
103
0.140
 Why?
Primary Health Care
1
2018
143
0.130
 Why?
Disease Progression
1
2018
450
0.130
 Why?
United States
1
2018
2035
0.100
 Why?
Adult
1
2021
7389
0.080
 Why?
Female
2
2022
14462
0.080
 Why?
Male
1
2019
12866
0.060
 Why?
Naloxone
1
2022
18
0.050
 Why?
Analgesics, Opioid
1
2022
102
0.050
 Why?
Practice Patterns, Physicians'
1
2022
160
0.050
 Why?
Cohort Studies
1
2022
860
0.040
 Why?
Aged
1
2022
5169
0.030
 Why?
Boylan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (12)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES